Preliminary study of positron emission tomography in the detection and management of orbital malignancy

Ophthalmic Plastic and Reconstructive Surgery

Volumn 22, Issue 5, 2006, Pages 361-365

  Lane, Katherine A ^a   Bilyk, Jurij R ^a  

^a WILLS EYE HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CARCINOMA; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPHOID HYPERPLASIA; LYMPHOMA; MALE; MELANOMA; METABOLISM; METASTASIS; NUCLEAR MAGNETIC RESONANCE IMAGING; ORBIT CANCER; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SARCOMA; TUMOR BIOPSY;

ADULT; AGED; BIOPSY; DIAGNOSIS, DIFFERENTIAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; ORBITAL NEOPLASMS; POSITRON-EMISSION TOMOGRAPHY; PROSPECTIVE STUDIES;

EID: 33748922437     PISSN: 07409303     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.iop.0000235493.82052.37     Document Type: Article

References (17)

1. Di Chiro G. Positron emission tomography using [18F] fluorodeoxyglucose in brain tumors: a powerful diagnostic and prognostic tool. Invest Radiol 1987;22:360-71.
2. Minn H, Joensuu H, Ahonen A, Klemi P. Fluorodeoxyglucose imaging: a method to assess the proliferative activity of human cancer in vivo: comparison with DNA flow cytometry in head and neck tumors. Cancer 1988;61:1776-8.
3. Modorati G, Lucignani G, Landoni C, et al. Glucose metabolism and pathological findings in uveal melanoma: preliminary results. Nucl Med Commun 1996;17:1052-6.
4. Brancato R, Lucignani G, Modorati G, et al. Metabolic imaging of uveal melanoma using positron emission tomography. Arch Ophthalmol 1990;108:326-7.
5. Lucignani G, Paganelli G, Modorati G, et al. MRI, antibody-guided scintigraphy, and glucose metabolism in uveal melanoma. J Comput Assist Tomogr 1992;16:77-83.
6. Freudenberg LS, Schueler AO, Beyer T, et al. Whole-body fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography (FDG-PET/CT) in staging of advanced uveal melanoma. Surv Ophthalmol 2004;49:537-40.
7. Spraul CW, Lang GE, Lang GK. Value of positron emission tomography in the diagnosis of malignant ocular tumors. Ophthalmologica 2001;215:163-8.
8. Moll AC, Hoekstra OS, Imhof SM, et al. Fluorine-Fluorine-18 fluorodeoxyglucose positron emission tomography (PET) to detect vital retinoblastoma in the eye: preliminary experience. Ophthalmic Genet 2004;25:31-5.
9. Laubenbacher C, Saumweber D, Wagner-Manslau C, et al. Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas. J Nucl Med 1995;36:1747-57.
10. Stokkel MP, Moons KG, ten Broek FW, et al. 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer. Cancer 1999;86:2370-7.
11. Hustinx R, Pourdehnad M, Kaschten B, Alavi A. PET imaging for differentiating recurrent brain tumor from radiation necrosis. Radiol Clin North Am 2005;43:35-47.
12. Lapela M, Eigtved A, Jyrkkio S, et al. Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer. Eur J Cancer 2000;36:858-67.
13. Okada J, Yoshikawa K, Imazeki K, et al. The use of FDG-PET in the detection and management of malignant lymphoma: correlation of uptake with prognosis. J Nucl Med 1991;32:686-91.
14. Valk PE, Budinger TF, Levin VA, et al. PET of malignant cerebral tumors after interstitial brachytherapy: demonstration of metabolic activity and correlation with clinical outcome. J Neurosurg 1988; 69:830-8.
15. Rege S, Safa AA, Chaiken L, et al. Positron emission tomography: an independent indicator of radiocurability in head and neck carcinomas. Am J Clin Oncol 2000;23:164-9.
16. Kumar R, Maillard I, Schuster SJ, Alavi A. Utility of fluorodeoxyglucose-PET imaging in the management of patients with Hodgkin's and non-Hodgkin's lymphomas. Radiol Clin North Am 2004;42:1083-100.
17. Seve P, Kodjikian L, Vautrin C, et al. Using 18F-fluoro-2-deoxyglucose positron emission tomography to detect primary lung cancer in an isolated choroidal metastasis. Arch Ophthalmol 2004; 122:1548-9.